Tesamorelin is a synthetic growth hormone releasing factor analogue consisting of the 44 amino acid sequence of human GRF with a trans-3-hexenoyl modification, supplied as a lyophilised powder in a sealed single-use vial for laboratory and analytical research purposes only. Stock is held and dispatched from Australia with tracking, typically within 1-2 business days of order.
Specifications - Compound: Tesamorelin (trans-3-hexenoyl-GRF 1-44). Format: lyophilised powder. Quantity: 5mg per vial. Purity: 98% minimum, analytically verified. Appearance: white lyophilised powder. Molecular weight: approximately 5135.9 g/mol. CAS number: 218949-48-5. Storage: 2-8 degrees C, sealed, protected from light. Intended use: laboratory research only.
Research context - Tesamorelin is a stabilised analogue of human growth hormone releasing factor, distinguished from shorter GHRH fragments by retaining the full 44 amino acid sequence with an N-terminal modification intended to resist enzymatic cleavage. Laboratory research focuses on comparative stability against unmodified GRF, receptor binding characteristics in in-vitro assays, and structural studies examining how N-terminal modification affects peptide conformation. Its considerably larger molecular weight relative to shorter secretagogues makes it useful in research comparing peptide size against diffusion and stability behaviour. Genesis Peptides supplies Tesamorelin in lyophilised form to preserve compound integrity during transport and storage.
Handling and storage - Store the sealed vial refrigerated at 2-8 degrees C and protect it from heat and light. Reconstitute using bacteriostatic water and follow established laboratory handling protocols. Reconstituted material has a materially shorter stable life than lyophilised powder and should be kept refrigerated.
Compliance notice - This product is supplied strictly for laboratory research use only. Not for human consumption, veterinary use, or therapeutic application. Not listed with the TGA. Genesis Peptides does not provide medical, therapeutic, or clinical guidance.
